
Not Just Pills — Cardiologists Must Talk Spirituality
At the 45th Congress of the Cardiology Society of the State of São Paulo, experts explored how this subjective dimension may contribute to fewer hospitalizations, better blood pressure control, and improved clinical outcomes in patients with heart disease.
Opening the discussion, cardiologist and hypertension specialist Fernando Nobre, MD, PhD, emphasized the important distinction between spirituality and religiosity. While often used interchangeably, the two are not synonymous. Religiosity refers to structured beliefs, practices, and rituals associated with faith and community life. In contrast, spirituality encompasses moral, emotional, and mental values that shape an individual's behavior and decision-making. These can be assessed using scientific frameworks.
'Religiosity is about how connected someone is to their religion — attendance at services, observance of rituals. That can be part of spirituality, but spirituality goes further. It cuts across and transcends a person's life, shaping their choices and way of living,' said Nobre, who is also a professor at the University of São Paulo, São Paulo, Brazil.
Patients with a stronger sense of spiritual engagement tend to have lower blood pressure and are less likely to develop hypertension. Studies suggest these effects may be linked to lower peripheral vascular resistance, improved cardiac output, and better adherence to prescribed treatment — particularly among women.
One recent example is the Brazilian Feel study, led by cardiologist Maria Emília Figueiredo Teixeira, MD, PhD, at the Brazilian Federal University of Goiás, Goiânia, Brazil. Cited by Nobre, the study was published in 2024 and followed 100 individuals with hypertension over 12 weeks. The intervention group received short, non-religious videos and messages promoting spiritual reflection — delivered via WhatsApp — and were encouraged to write about gratitude, forgiveness, life purpose, and optimism.
The group receiving the intervention showed a more significant drop in blood pressure and notable improvement in endothelial function, measured through flow-mediated dilation.
'If spirituality appears to influence both key components of blood pressure, that alone is reason enough for us to understand it better,' said Nobre.
Heart Failure: Fewer Hospitalizations, Better Quality of Life
In patients with heart failure, spirituality may influence not only psychological resilience but also the underlying pathophysiology of the disease. Studies have found that individuals with greater spiritual engagement show reduced sympathetic nervous system activity, lower levels of stress hormones, and decreased inflammatory cytokines. Clinically, these changes are associated with fewer symptoms, fewer hospitalizations, and an improved quality of life.
At the session, cardio-oncologist Rafael Nunes, MD, PhD, of the Oswaldo Cruz German Hospital, São Paulo, highlighted a 2022 review published in JACC: Heart Failure . The review analyzed 47 studies examining spirituality in heart failure patients. Despite differences in methodology, the evidence consistently linked higher spirituality levels with lower rates of anxiety and depression, improved adherence to treatment, fewer hospital admissions, and, in some cases, reduced mortality.
A follow-up review published in 2023 reinforced these findings and added an important distinction: Participation in religious organizations alone was not sufficient to deliver clinical benefit. 'It's the spiritual experience — the meaning a person assigns to their life, beliefs, and motivations — that is associated with positive outcomes,' explained Nunes.
Another study underscored this point. Titled Is Belonging to a Religious Organization Enough? , the study separately assessed the effects of religiosity and spirituality. The results showed that spirituality was linked to lower levels of anger, anxiety, and emotional exhaustion. In contrast, religiosity alone — without deeper personal engagement — did not significantly impact emotional well-being.
Coronary Artery Disease: Stress and Acute Cardiac Events
While coronary artery disease can remain stable for years, its progression into acute myocardial infarction — one of the leading global causes of death — can be sudden and unpredictable. Although plaque accumulation is gradual, rupture events are often triggered by acute neuro-immuno-hormonal and inflammatory responses.
Roberto Veiga Giraldez, MD, PhD, director of the Acute Coronary Care Unit at the Heart Institute, Hospital das Clínicas, University of São Paulo, cited research linking acute myocardial infarction to external stressors such as natural disasters or high-stakes sporting events. During these situations, sympathetic nervous system activation and systemic inflammation intensify, raising the risk of acute coronary syndromes.
One study cited by Giraldez was conducted in South Korea, where cities vulnerable to earthquakes experienced a significant spike in acute coronary syndrome cases immediately following seismic events. Incidence peaked shortly after the quakes and gradually declined over time.
Another analysis focused on the 2006 FIFA World Cup. In several German cities, rates of myocardial infarction rose during high-stakes national team matches — especially during tense or decisive games. The highest incidence occurred in the early minutes of play, when fan anxiety was likely at its peak.
'These data illustrate how acute stress can influence outcomes in patients with coronary artery disease,' said Giraldez. 'Spirituality can help mitigate this impact. Resignation and faith — whatever form they take — can help individuals face stressful situations with greater composure.'
How Should Clinicians Address Spirituality?
According to Nunes, spirituality should be systematically integrated into clinical practice — always with sensitivity to the patient's values, preferences, and boundaries. 'We should approach spirituality with the same seriousness we apply to mental health and lifestyle habits. Understanding what matters to the patient and why they seek care can shape the therapeutic journey,' he said.
He advocated for incorporating spiritual assessment into palliative care and broader multidisciplinary strategies, particularly in advanced stages of heart failure. 'Nutritionists, nurses, psychologists — everyone can play a role in listening,' he added.
Nobre emphasized that addressing spirituality doesn't have to be complex — just intentional. 'During the medical history, when we ask about lifestyle, why not also ask how the illness is affecting them emotionally? Or whether they believe in something greater? For some, spirituality may be irrelevant, and that's fine. But if it matters to the patient, it can become a powerful ally — especially in supporting treatment adherence.'
'We're not necessarily talking about religion,' he continued. 'A person might be Catholic, Evangelical, Umbandist, or have no religion at all. The point is: Does it matter to them? When we make that connection, care moves beyond the physical body. It becomes whole-person care — addressing mind, emotions, and values. And that's when medicine reaches its fullest potential,' Nobre concluded.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
an hour ago
- Associated Press
The National Council for Occupational Safety and Health Receives an International Award at the 25th ORP Conference in Colombia
The National Council for Occupational Safety and Health (NCOSH) participated in the 25th Annual Conference of the International ORP Foundation (Occupational Risk Prevention), held from July 31 to August 1, 2025, in Cartagena de Indias, Colombia. The ORP Conference is one of the most prominent international events dedicated to occupational safety and health in South America. CARTAGENA, CO / ACCESS Newswire / August 4, 2025 / The National Council for Occupational Safety and Health (NCOSH) participated in the 25th Annual Conference of the International ORP Foundation (Occupational Risk Prevention), held from July 31 to August 1, 2025, in Cartagena de Indias, Colombia. The ORP Conference is one of the most prominent international events dedicated to occupational safety and health in South National Council for Occupational Safety and Health Receives an International Award at the 25th The National Council for Occupational Safety and Health (NCOSH) participated in the 25th Annual Conference of the International ORP Foundation (Occupational Risk Prevention), held from July 31 to August 1, 2025, in Cartagena de Indias, Colombia. The NCOSH was represented by its Secretary-General, Eng. Majed bin Ibrahim Alfuwaiz, who shared Saudi Arabia's experience in advancing its occupational safety and health ecosystem. The presentation highlighted key national initiatives and achievements in line with the objectives of the Kingdom of Saudi Arabia's Vision 2030. At the conclusion of the conference, Eng. Alfuwaiz accepted the 'ORP Recognition 2025" award on behalf of the Council. This prestigious international award is presented annually by the ORP Foundation to organizations that have demonstrated impactful efforts in promoting safe and healthy workplaces. This recognition marks a milestone in NCOSH's efforts to strengthen the culture of occupational safety and health in the Kingdom, through coordination with national stakeholders and the adoption of global best practices in pursuit of Vision 2030 objectives. This achievement stands as a distinguished addition to Saudi Arabia's international record, placing NCOSH alongside renowned institutions that have previously received this award, including International Labour Organization (ILO), International Commission on Occupational Health (ICOH), World Health Organization (WHO), Institution of Occupational Safety and Health (IOSH UK), International Social Security Association (ISSA) and German Social Accident Insurance (DGUV) On this occasion, Eng. Majed Alfuwaiz expressed his pride in this national achievement, stating that it was made possible-first by the grace of Allah, then through the continuous support of the Kingdom's leadership and the guidance of His Excellency the Minister of Human Resources and Social Development (HRSD), who chairs the Council, along with His Excellency the Vice Minister of HRSD. Their leadership has been instrumental in enabling NCOSH to fulfill its mission effectively. He also extended his gratitude to the NCOSH Secretariat and all those who contributed to the Council's initiatives. He affirmed the Council's continued commitment to enhancing worker protection and achieving sustainable institutional excellence in this vital field Contact Information PUREMINDS Agency المجلس الوطني للسلامة والصحة المهنية | Ncosh [email protected] +966 55 180 6364 SOURCE: National Council for Occupational Safety and Health press release


New York Times
a day ago
- New York Times
A Cancer Patient Chose Assisted Death. That Wasn't the Last Hard Choice.
The crowd was expectant when Tatiana Andia took the microphone: She was a hero to many in the room, the woman who negotiated cheaper drug prices for Colombia. But that day, at a conference for policymakers and academics on the right to health in Latin America, there was a more intimate topic she wanted to discuss. 'A year ago I was diagnosed with a terminal lung cancer,' she began, 'one that's incurable, catastrophic, all the terrible adjectives.' She gave a small laugh, acknowledging the whole thing sounded preposterous. The air in the packed conference room went still. Ms. Andia, 44, a professor and a former official in Colombia's health ministry, said she was going to speak not as an expert, but from a different perspective, one newly acquired — that of a patient. A particular health rights issue preoccupied her these days, she said: the right to death. No one, she went on, wants to talk to me about dying. She began to speak faster and faster, and her hands fluttered around her face like small birds. People in the audience looked at the floor, the ceiling, their laps. 'How come we can't talk about having a dignified death when we talk about the right to health?' she demanded. Want all of The Times? Subscribe.
Yahoo
2 days ago
- Yahoo
Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating
Imagine shedding weight while sitting quietly watching TV, even without cutting calories. A pioneering pill called SANA, created by Uruguayan startup Eolo Pharma, could one day make that possible. Early human data in a statement by Eolo Pharma shows it can burn fat even at rest, without appetite suppression or serious side effects. That breakthrough could reshape global obesity treatment. Biotech Startup Pioneers First-in-Class Therapies to Treat Obesity and Metabolic Disease Eolo Pharma is a clinical-stage biotechnology company focused on pioneering therapies for obesity and metabolic diseases. The company says it develops first-in-class small-molecule drugs that activate the body's own energy-burning pathways rather than relying on appetite suppression. Its lead candidate, SANA, is the first compound shown to safely activate creatine-dependent thermogenesis in humans, offering a novel approach to resetting metabolic health. Don't Miss: Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Headquartered in Delaware with strong scientific roots in South America, Eolo Pharma is a spin-off of the Institut Pasteur de Montevideo, a non-profit foundation that promotes scientific and technological research. The company says it is backed by more than a decade of research into metabolic disorders and cardiometabolic complications. Eolo Pharma's proprietary library of 60 novel chemical entities includes molecules designed to address high-burden, non-communicable diseases such as obesity, type 2 diabetes, non-alcoholic steatohepatitis, hypertension, amyotrophic lateral sclerosis, and Alzheimer's disease. Eolo Pharma's leadership team includes CEO María Pía Garat, a biotech industry leader with a postgraduate degree from Instituto de Empresa Business School; co-founder and Chief Scientific Officer Carlos Escande, a former Mayo Clinic investigator specializing in cardiometabolic disorders; Chief Chemistry Officer Virginia Lopez, a chemist from Uruguay; and Chief Medical Officer Carlos Batthyany, who also serves as head of the Institut Pasteur de Montevideo. Trending: $100k+ in investable assets? – no cost, no obligation. How SANA Activates Fat Burning Without Appetite Suppression SANA is a salicylate‑based nitroalkene compound originally developed to target inflammation, Eolo Pharma says. It was repurposed after researchers discovered it stimulates creatine‑dependent thermogenesis in white and brown fat cells. Unlike glucagon-like peptide‑1 drugs like Ozempic, which reduce hunger, SANA boosts energy expenditure in fat tissue by turning on heat‑producing metabolic pathways at cellular level. According to Eolo Pharma, SANA protected lean mass and reduced fat more than standard salicylate or metformin in preclinical models. "This is the first time a drug has been shown to pharmacologically activate creatine-based thermogenesis, which could lead to a novel therapeutic approach for obesity in humans," Escande said in the statement. "It opens up an entirely new therapeutic pathway for obesity and metabolic disorders."Weight Loss, Glucose Benefits, and Safety Signals In a randomized, double‑blind, placebo‑controlled Phase 1a/b clinical trial, participants received single ascending doses or multiple ascending doses of SANA for 15 days. The trial included 17 healthy lean volunteers and 24 individuals with obesity. According to Eolo Pharma, patients receiving SANA experienced a statistically significant reduction in body weight compared to placebo, along with improvements in fasting glucose and insulin resistance as measured by Homeostatic Model Assessment of Insulin Resistance. No serious adverse events occurred, and only mild headaches and soft stools were reported in some subjects. A Nature Metabolism study published in June describes SANA as a first‑in‑class small molecule that activates creatine‑dependent thermogenesis in preclinical models and shows safety and early metabolic benefits in a phase 1A/B trial in humans. The authors suggest SANA as a promising therapeutic candidate for obesity, though they note that its efficacy in humans requires further confirmation in larger trials. Read Next: The average American couple has saved this much money for retirement —? Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Meet The Biotech Startup Challenging Ozempic With A Fat-Burning Pill That Lets You Keep Eating originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.